Native American tribe not entitled to sovereign immunity: PTAB
26-02-2018
Is the Allergan patent deal a misuse of sovereign immunity?
19-09-2017
wildpixel / iStockphoto.com
The dispute arises from the biotechnology company Gensetix’s acquisition of exclusive licencing of US patent numbers 8,728,806 and 9,333,248 from the University of Texas in 2014.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Gensetix, Baylor College of Medicine, University of Texas, patents, lawsuit
